|
CCT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.118400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.212000E-01 |
| Normal-vs-Stage2 |
9.842200E-01 |
| Normal-vs-Stage3 |
1.403270E-03 |
| Normal-vs-Stage4 |
3.637900E-03 |
| Stage1-vs-Stage2 |
8.127200E-01 |
| Stage1-vs-Stage3 |
1.001280E-03 |
| Stage1-vs-Stage4 |
2.37199999999493E-05 |
| Stage2-vs-Stage3 |
3.241400E-03 |
| Stage2-vs-Stage4 |
4.193900E-04 |
| Stage3-vs-Stage4 |
5.749600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.704100E-02 |
| Normal-vs-AfricanAmerican |
5.751200E-01 |
| Normal-vs-Asian |
4.343600E-01 |
| Caucasian-vs-AfricanAmerican |
5.098600E-01 |
| Caucasian-vs-Asian |
3.608800E-01 |
| AfricanAmerican-vs-Asian |
4.928000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.511200E-01 |
| Normal-vs-Female |
7.004600E-04 |
| Male-vs-Female |
1.703900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.801600E-02 |
| Normal-vs-Extreme_Weight |
5.606800E-01 |
| Normal-vs-Obese |
7.761700E-02 |
| Normal-vs-Extreme_Obese |
9.769400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.628300E-02 |
| Normal_Weight-vs-Obese |
8.852200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.638400E-01 |
| Extreme_Weight-vs-Obese |
4.843800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.925600E-01 |
| Obese-vs-Extreme_Obese |
4.670400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.371950E-02 |
| Normal-vs-Age(41-60Yrs) |
1.180840E-01 |
| Normal-vs-Age(61-80Yrs) |
5.107000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.127800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.260900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.201700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.045620E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.363000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.938600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.935800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.301640E-01 |
| Normal-VS-Type2 PRCC |
8.806100E-04 |
| Normal-VS-KIRP CIMP |
4.875400E-03 |
| Normal-VS-Unclassified PRCC |
2.711400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.7219999999989E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.964300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.112200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.880400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.756580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.061000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.806800E-01 |
| Normal-vs-N1 |
8.01150000000472E-05 |
| Normal-vs-N2 |
2.35060000000065E-05 |
| N0-vs-N1 |
2.838900E-04 |
| N0-vs-N2 |
1.191210E-01 |
| N1-vs-N2 |
4.637200E-01 |
|
|
